Finance

Lists
CUV:ASX
Clinuvel Pharmaceuticals Ltd
8,20 A$
+0,86%
(+0,070) 1D
7 қаз., 16:10:07 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for CUV...
Open
8,13 A$
High
8,26 A$
Low
8,05 A$
Mkt. cap
414,08 млн
Avg. vol.
164,84 м.
Volume
82,56 мың
Dividend
0,61%
Quarterly dividend
0,01 A$
Ex-dividend date
2026 ж. 03 қыр.
P/E ratio
12,73
52-wk high
13,48 A$
52-wk low
7,93 A$
EPS
0,64 A$
Shares outstanding
50,49 млн
No. of employees
16
Open
8,13 A$
High
8,26 A$
Low
8,05 A$
Mkt. cap
414,08 млн
Avg. vol.
164,84 м.
Volume
82,56 мың
Dividend
0,61%
Quarterly dividend
0,01 A$
Ex-dividend date
2026 ж. 03 қыр.
P/E ratio
12,73
52-wk high
13,48 A$
52-wk low
7,93 A$
EPS
0,64 A$
Shares outstanding
50,49 млн
No. of employees
16
News stories
From web sources and news partners
About Clinuvel Pharmaceuticals Ltd
CEOPhilippe J. Wolgen
Employees16
Founded1987
Headquarters-
Sector-
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
18,47 млн
18,47 млн
28,55 млн
28,55 млн
Cost of goods sold
2,28 млн
2,28 млн
5,62 млн
5,62 млн
Cost of revenue
2,28 млн
2,28 млн
5,62 млн
5,62 млн
Research and development expenses
1,70 млн
1,70 млн
7,35 млн
7,35 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,96 млн
6,96 млн
2,83 млн
2,83 млн
Operating expense
9,42 млн
9,42 млн
9,42 млн
9,42 млн
Total operating expenses
11,71 млн
11,71 млн
15,04 млн
15,04 млн
Operating income
6,76 млн
6,76 млн
13,51 млн
13,51 млн
Other non operating income
-
-
322,45 м.
322,45 м.
EBT including unusual items
7,29 млн
7,29 млн
16,54 млн
16,54 млн
EBT excluding unusual items
7,29 млн
7,29 млн
16,54 млн
16,54 млн
Income tax expense
2,07 млн
2,07 млн
4,80 млн
4,80 млн
Effective tax rate
28,39%
28,39%
29,03%
29,03%
Other operating expenses
-1,24 мың
-1,24 мың
1,24 мың
1,24 мың
Net income
5,22 млн
5,22 млн
11,74 млн
11,74 млн
Net profit margin
28,28%
28,28%
41,11%
41,11%
Earnings per share
-
-
-
-
Interest and investment income
2,63 млн
2,63 млн
3,87 млн
3,87 млн
Interest expense
-1,28 млн
-1,28 млн
-
-
Net interest expenses
1,35 млн
1,35 млн
3,87 млн
3,87 млн
Depreciation and amortization charges
250,02 м.
250,02 м.
-250,02 м.
-250,02 м.
EBITDA
7,01 млн
7,01 млн
13,55 млн
13,55 млн
Gain or loss from assets sale
-
-
28,62 мың
28,62 мың
AI content may include mistakes. Learn more
Google қолданбалары